SCHEMBL9604039

SCHEMBL9604039

c1ccc2cc(-c3ccc(-c4cccc5nc(-c6ccc(-c7cccc8c7oc7ccccc78)cc6)oc45)cc3)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.48
DHODH Q02127 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
PRKDC P78527 2/20 0.39
NPC1 O15118 4/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 2/20 0.39
PDE4C Q08493 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
RAB9A P51151 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
GGPS1 O95749 1/20 0.37
CYP1A2 P05177 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9604033 0.96 ALOX5 (0.52) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL9604036 0.89 ALOX5 (0.52) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL9604035 0.89 DHODH (0.53) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL17167457 0.89 ALOX5 (0.58) ALOX5ESR1ESR2PRKDCNPC1
SCHEMBL8281440 0.88 ALDH1A1 (0.50) ALOX5ESR1ALDH1A1MAPTPRKDC
SCHEMBL9604038 0.88 ALOX5 (0.49) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL9604034 0.87 ALOX5 (0.51) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL9604031 0.86 ALOX5 (0.48) ALOX5DHODHESR1ESR2ALDH1A1
SCHEMBL9603977 0.85 NPC1 (0.54) ALOX5DHODHALDH1A1MAPTNPC1
SCHEMBL26833870 0.85 ALOX5 (0.39) ALOX5ALDH1A1MAPTPRKDCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-8546584-B2 Benzoxazole derivative, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-10-01 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132896-A1 Benzoxazole Derivative, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device XDH, AOX1, CYP4X1 ALOX5 720/4885DHODH 1631/4885ESR1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.